The Vaccination
Information about supplied vaccines, effectiveness and the vaccination rollouts
Characteristics of COVID-19 Vaccines
COVID-19 vaccines are effective in preventing severe illness and symptoms such as fever or coughs. Vaccination is expected to reduce the number of severe COVID-19 patients and deaths.
Some cases of side effects such as localized pain in the injected site, headache, fatigue, muscle and joint pain, and anaphylaxis (acute allergic reaction) after vaccination in some rare cases have been reported.
Through their pharmaceutical approvals, effectiveness and safety of vaccines for COVID-19 has been verified based on clinical trials and scientific findings.
Available Vaccines
Vaccines available in Japan are currently from Pfizer and Moderna.
- Pfizer Inc.
- Vaccine name: Comirnaty
Pharmaceutical approval: February 14, 2021
Vaccine type: mRNA vaccine Number of times to administer: twice Vaccination interval: 21 days
Click here
for details of the vaccine - Takeda Pharmaceutical Company Limited/Moderna Inc.
- Vaccine name: Moderna COVID-19 vaccine
Pharmaceutical approval: May 21, 2021
Vaccine type: mRNA vaccine Number of times to administer: twice Vaccination interval: 28 days
Click here for details of the vaccine
Vaccination rollouts in Japan (by prefecture)
Please refer to here.
Novel Coronavirus Vaccination Q&A Website
We answer the questions about the effectiveness of the novel coronavirus vaccines, their safety, and your eligibility.
